Dear John,

The March issue of Health Affairs features articles on a range of topics, including prescription drug policy, use, and patent challenges; physician turnover after private equity acquisition of physician practices; children’s health coverage loss during Medicaid unwinding; and more.

P H A R M A C E U T I C A L S 

Demographic Variation In US Outpatient Hydroxychloroquine And Ivermectin Use During The COVID-19 Pandemic

Michelle S. Rockwell et al.

Estimated Savings From Extending Prescription Drug Inflationary Rebates To All Commercial Plans

Marissa B. Reitsma et al.

First-In-Class Drugs Experienced Different Regulatory Treatment In The US And Europe

Jihye Han and Aaron S. Kesselheim

Changes In Biologic Drug Revenues After Administrative Patent Challenges

Adam J. N. Raymakers et al.

P R I V A T E   E Q U I T Y

Physician Turnover Increased In Private Equity–Acquired Physician Practices

Yashaswini Singh et al.

C H I L D   H E A L T H

Continuous Eligibility Policies And CHIP Structure Affected Children’s Coverage Loss During Medicaid Unwinding

Erica Eliason

Medicaid's Uncertain Future

The Medicaid program has historically faced political challenges, especially during the first Trump administration.

With the recently seated second Trump administration, there are a variety of changes under consideration for the Medicaid program and its beneficiaries.

Join Health Affairs on March 19 to discuss what policy changes may occur and how they may impact the Medicaid market and patients.

The panel will discuss interesting research questions that could be asked during this time. From work requirements to state funding, the panel will share its perspective and give space to address questions from the audience.

Confirmed speakers include:

• Carmel Shachar, Harvard Law (Moderator)
• Jennifer Tolbert, KFF
• Edwin Park, Georgetown University
• Aditi Vasan, University of Pennsylvania

This event is for Health Affairs Insiders only.

Recent Events Have Made Primary Care More Fragile—Further Challenges Lie Ahead

Carole Johnson

Medicare Coverage Of Medical Technologies In A New Era

Sean R. Tunis et al.

When Executive Directives And Public Health Ethics Collide

Ronald O. Valdiserri et al.

Rewarding Medicare Advantage D-SNPs That Provide The Best Value

Ryan Stringer et al.

part of our Medicare and Medicaid Integration series

An Argument For A New Medicare Prospective Payment System Methodology For Certified Community Behavioral Health Clinics

Joshua Pearson

Prescribing Buprenorphine By Telehealth: Lessons From San Francisco Amidst A Changing Regulatory Landscape

Jeffrey K. Horn et al.

Supporting Family Caregivers In Hospital At Home

Rani E. Snyder

To Ensure Children's Health, Create Affordable Housing In High-Opportunity Neighborhoods

Michael J. Luke et al.

Congress Can Unlock The Full Potential Of Telehealth Through A Permanent Fix

Ateev Mehrotra and Jared Perkins

Reporting Requirements Matter (A Lot): Evidence From Arkansas's Medicaid Work Requirements

Morgan A. Henderson et al.

A Health Podyssey: Jihye Han Compares First-In-Class Drug Regulation in the US and Europe

Health Affairs' Senior Deputy Editor Rob Lott interviews Jihye Han of Brigham and Women's Hospital and Harvard University on her recent paper that takes a closer look at the regulatory treatments for first-in-class drugs and how those differ between the US and Europe.

Health Affairs This Week: The Impact of Trump's Known Health Care Agenda w/ Rebecca Pifer

Health Affairs' Jeff Byers welcomes Rebecca Pifer of Healthcare Dive back to the program to discuss the 2025 budget resolution that passed the House on its way to the Senate, the current administration's health care agenda, and what ripple effects the current actions of DOGE are having on the health care workforce.